A Randomized, Phase II Study of Apalutamide +/− Stereotactic Body Radiotherapy (SBRT) in Castration‐Resistant Prostate Cancer Patients With Oligometastatic Disease on PSMA‐PET Imaging. This evidence concerns the gene FOLH1 and prostate cancer.